Akums Drugs and Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Akums Drugs and Pharmaceuticals (AKUMS) Key Ratios
Akums Drugs and Pharmaceuticals Share Price Analysis Local DB
Akums Drugs and Pharmaceuticals share price is ₹770.25, day high (share price) is ₹794.90, day low (share price) is ₹768.20 and volume is 750,068. 52 Week high share price for Akums Drugs and Pharmaceuticals is ₹796.55 on 01 Sep 2026 and 52 week low share price for Akums Drugs and Pharmaceuticals is ₹409.30 on 21 Jan 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Akums Drugs and Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 62.4, 50 DMA (50 Displaced Moving Average) is 696.22 and 200 DMA (200 Displaced Moving Average) is 537.83.
Akums Drugs and Pharmaceuticals (AKUMS) Technical Analysis
Akums Drugs and Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Akums Drugs and Pharmaceuticals Oscillators Analysis
Akums Drugs and Pharmaceuticals Price Action
Akums Drugs and Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 62.37 |
| Stoch %K (14, 3, 3) | 78.12 |
| CCI (20) | 97.11 |
| ADX (14) | 45.25 |
| Awesome Osc | 55.98 |
| Momentum (10) | 16.95 |
| MACD (12, 26, 9) | 24.41 |
| MACD Signal | 24.84 |
| Stoch RSI (14) | 48.80 |
| Williams %R (14) | -32.29 |
| Bull/Bear Power | 46.00 |
| Ultimate Osc | 34.73 |
| MFI (14) | 67.63 |
| ROC (21) | 15.41 |
| ROC (125) | 57.79 |
| ATR (14) | 25.76 |
Akums Drugs and Pharmaceuticals Moving Averages
| Ichimoku Base | 725.08 | Above Base |
| VWMA (20) | 748.68 | Above VWMA |
| HMA (9) | 779.99 | Below HMA |
Akums Drugs and Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- RSI at 62.37 indicates relatively strong momentum without being overbought.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Akums Drugs and Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 818.55 | 815.88 | 785.99 | 807.55 |
| Resistance 2 | 807.55 | 806.21 | 783.68 | 797.90 |
| Resistance 1 | 793.30 | 790.63 | 781.36 | 791.95 |
| Pivot Point | 782.30 | 780.96 | 779.05 | 782.30 |
| Support 1 | 768.05 | 765.38 | 776.74 | 772.65 |
| Support 2 | 757.05 | 755.71 | 774.42 | 766.70 |
| Support 3 | 742.80 | 740.13 | 772.11 | 757.05 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Akums Drugs and Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 75.26% | 75.26% | 75.26% | 75.26% |
| FII | 1.91% | 1.37% | 1.15% | 2.28% |
| DII (Other) | 3.67% | 3.40% | 3.18% | 2.84% |
| Retail & Others | 9.39% | 9.02% | 9.19% | 13.19% |
| Mutual Funds | 9.77% | 10.95% | 11.23% | 6.44% |
Akums Drugs and Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 4,487.75 +7.61% | 382.10 +10.67% | 256.40 -25.42% |
| Mar 2025 | 4,170.28 -1.0% | 345.25 +862.48% | 343.78 +43416.46% |
| Mar 2024 | 4,212.21 +13.81% | -45.28 -130.13% | 0.79 -99.19% |
| Mar 2023 | 3,700.93 | 150.30 | 97.82 |
Akums Drugs and Pharmaceuticals - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 03 Jul 2026 | ₹1 | View Details |
|
Announcement date
15 May 2026
Ex dividend date
03 Jul 2026
Record date
03 Jul 2026
Dividend type
Final
Amount
1.0
Dividend %
50.0
Details
Rs.1.0000 per share(50%)Final Dividend
|
|||
| Dividend | 03 Jul 2026 | ₹2 | View Details |
|
Announcement date
16 May 2026
Ex dividend date
03 Jul 2026
Record date
03 Jul 2026
Dividend type
Special
Amount
2.0
Dividend %
100.0
Details
Rs.2.0000 per share(100%)Special Dividend
|
|||
